Status | Study |
Recruiting |
Study Name: Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening Condition: Congenital Cytomegalovirus Infection Date: 2014-04-28 Interventions: Other: CMV PCR Other Name: CMV PCR results are communicated to the relevant clinicians in real time. |
Recruiting |
Study Name: Congenital Cytomegalovirus: Efficacy of Antiviral Treatment Condition: Congenital Cytomegalovirus Infection Sensorineural Hearing Loss Date: 2013-12-04 Interventions: Drug: Valganciclovir Infants will be treated with valganciclovir for 6 weeks, 32 mg/kg daily dose in two |
Recruiting |
Study Name: Prognostic Value of Neonatal Markers (Clinical, Imaging and Biological) for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus (CMV) in Utero Condition: Congenital Cytomegalovirus Infection Date: 2013-08-13 Interventions: Other: Standardized test report Clinical, radiological and laboratory (virological and immunological) st |
Completed |
Study Name: Clinical Trial of Behavioral Modification to Prevent Congenital Cytomegalovirus Condition: Cytomegalovirus Infections Pregnancy Behavior Date: 2013-03-18 Interventions: Behavioral: Educational Intervention The patient will told if previously infected or seronegative and wh |
Recruiting |
Study Name: Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection Condition: Cytomegalovirus Congenital Infection Date: 2012-08-01 Interventions: Biological: standard intravenous immunoglobulin Human standard intravenous immunoglobulin (IVIG), 0.5 g/ |
Recruiting |
Study Name: Congenital CMV and Hearing Loss in Children up to 4 Years of Age: Treating With Valganciclovir Therapy Condition: Congenital Cytomegalovirus Hearing Loss Date: 2012-07-20 Interventions: Drug: Valcyte (Valganciclovir hydrochloride) Powder for oral solution |
Terminated |
Study Name: Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial Condition: Congenital Cytomegalovirus Infection Sensorineural Hearing Loss Date: 2012-07-13 Interventions: Drug: Valganciclovir Infants will be treated with valganciclovir for 6 weeks, 32 mg/kg daily dose in two |
Recruiting |
Study Name: A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) Condition: Congenital Cytomegalovirus Infection Maternal Cytomegalovirus I Date: 2011-06-15 Interventions: Drug: CMV hyperimmune globulin The study's active drug is Cytogam® which is an immunoglobulin G (Ig |
Terminated |
Study Name: In UTERO Treatment of Cytomegalovirus Congenital Infection With Valacyclovir Condition: Viral Disease Cytomegalovirus Infection Date: 2009-12-21 Interventions: Drug: Valacyclovir (ZELITREX) |
Completed |
Study Name: Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections Condition: Cytomegalovirus Infection Date: 2007-04-26 Interventions: Other: Placebo 9 grams of powd |